A Clinical Study of Recombinant Human Coagulation Factor VIII for Injection in Patients With Severe Hemophilia A
Condition(s):Hemophilia ALast Updated:March 7, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Hemophilia ALast Updated:March 7, 2024Not yet recruiting
Condition(s):Hemophilia ALast Updated:April 6, 2023Recruiting
Condition(s):Hemophilia ALast Updated:August 22, 2023Completed
Condition(s):Hemophilia ALast Updated:April 4, 2017Completed
Condition(s):Severe Hemophilia ALast Updated:June 9, 2022Completed
Condition(s):Hemophilia ALast Updated:August 19, 2019Unknown status
Condition(s):Hemophilia ALast Updated:February 23, 2021Terminated
Condition(s):Hemophilia ALast Updated:March 17, 2021Completed
Condition(s):Severe Hemophilia A Without InhibitorLast Updated:July 20, 2022Completed
Condition(s):Hemophilia ALast Updated:December 19, 2020Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.